Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiotherapy Planning, Computer-Assisted | 13 | 2021 | 2370 | 1.050 |
Why?
|
| Movement | 11 | 2008 | 556 | 1.020 |
Why?
|
| Radiotherapy, Computer-Assisted | 4 | 2009 | 126 | 0.940 |
Why?
|
| Respiration | 10 | 2015 | 447 | 0.860 |
Why?
|
| Four-Dimensional Computed Tomography | 3 | 2019 | 226 | 0.580 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2009 | 925 | 0.520 |
Why?
|
| Radiotherapy, Intensity-Modulated | 6 | 2021 | 2104 | 0.430 |
Why?
|
| Radiotherapy, Conformal | 3 | 2016 | 902 | 0.400 |
Why?
|
| Algorithms | 6 | 2015 | 3890 | 0.330 |
Why?
|
| Pattern Recognition, Automated | 1 | 2009 | 125 | 0.330 |
Why?
|
| Motion | 6 | 2015 | 193 | 0.330 |
Why?
|
| Radiometry | 4 | 2016 | 980 | 0.310 |
Why?
|
| Range of Motion, Articular | 1 | 2008 | 144 | 0.310 |
Why?
|
| Respiratory Mechanics | 1 | 2008 | 173 | 0.300 |
Why?
|
| Abdominal Neoplasms | 2 | 2008 | 231 | 0.290 |
Why?
|
| Thoracic Neoplasms | 1 | 2008 | 337 | 0.260 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2007 | 262 | 0.250 |
Why?
|
| Radiotherapy Dosage | 9 | 2021 | 3842 | 0.250 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2007 | 361 | 0.240 |
Why?
|
| Breath Holding | 2 | 2019 | 44 | 0.210 |
Why?
|
| Liver Neoplasms | 3 | 2019 | 4557 | 0.200 |
Why?
|
| Radiotherapy, Image-Guided | 2 | 2019 | 304 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2009 | 7551 | 0.170 |
Why?
|
| Phantoms, Imaging | 3 | 2016 | 1271 | 0.160 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2019 | 202 | 0.160 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2019 | 1648 | 0.160 |
Why?
|
| Chemoradiotherapy | 2 | 2016 | 1946 | 0.150 |
Why?
|
| Lung Neoplasms | 5 | 2008 | 11538 | 0.150 |
Why?
|
| Fourier Analysis | 1 | 2015 | 94 | 0.130 |
Why?
|
| Lymphopenia | 1 | 2016 | 199 | 0.120 |
Why?
|
| Spleen | 1 | 2016 | 676 | 0.120 |
Why?
|
| Organs at Risk | 1 | 2016 | 514 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 3 | 2016 | 5061 | 0.110 |
Why?
|
| Quality Assurance, Health Care | 1 | 2016 | 585 | 0.100 |
Why?
|
| Radiography | 3 | 2015 | 1904 | 0.100 |
Why?
|
| Artifacts | 2 | 2015 | 532 | 0.090 |
Why?
|
| Time Factors | 7 | 2016 | 12926 | 0.080 |
Why?
|
| Biofeedback, Psychology | 1 | 2008 | 49 | 0.080 |
Why?
|
| Proton Therapy | 1 | 2019 | 1577 | 0.080 |
Why?
|
| Audiovisual Aids | 1 | 2008 | 42 | 0.080 |
Why?
|
| Neoplasms | 3 | 2013 | 15193 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 2027 | 0.070 |
Why?
|
| Humans | 21 | 2021 | 261506 | 0.070 |
Why?
|
| Sensitivity and Specificity | 4 | 2011 | 4971 | 0.070 |
Why?
|
| Abdomen | 1 | 2005 | 332 | 0.060 |
Why?
|
| Feedback | 1 | 2004 | 198 | 0.060 |
Why?
|
| Induction Chemotherapy | 2 | 2016 | 669 | 0.050 |
Why?
|
| Feasibility Studies | 2 | 2004 | 2292 | 0.050 |
Why?
|
| Radiotherapy | 1 | 2007 | 1824 | 0.050 |
Why?
|
| Radiosurgery | 1 | 2009 | 1330 | 0.050 |
Why?
|
| Skin | 1 | 2004 | 1259 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2019 | 32848 | 0.040 |
Why?
|
| Uncertainty | 1 | 2019 | 320 | 0.040 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2019 | 726 | 0.040 |
Why?
|
| Equipment Design | 2 | 2011 | 1204 | 0.030 |
Why?
|
| Calibration | 1 | 2016 | 337 | 0.030 |
Why?
|
| Gamma Rays | 1 | 2016 | 242 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2016 | 486 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2015 | 181 | 0.030 |
Why?
|
| Radiography, Abdominal | 1 | 2015 | 120 | 0.030 |
Why?
|
| Fluoroscopy | 2 | 2005 | 232 | 0.030 |
Why?
|
| Particle Accelerators | 1 | 2016 | 352 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 29902 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2015 | 462 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2016 | 2316 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2011 | 329 | 0.020 |
Why?
|
| Aged | 4 | 2019 | 70117 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2015 | 1987 | 0.020 |
Why?
|
| Logistic Models | 1 | 2016 | 3441 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 6207 | 0.020 |
Why?
|
| Middle Aged | 4 | 2019 | 86204 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2011 | 6009 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 4988 | 0.020 |
Why?
|
| Disease Progression | 1 | 2019 | 6682 | 0.020 |
Why?
|
| Male | 5 | 2019 | 123000 | 0.020 |
Why?
|
| Computers | 1 | 2007 | 141 | 0.020 |
Why?
|
| Robotics | 1 | 2011 | 359 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2015 | 37905 | 0.020 |
Why?
|
| Female | 5 | 2019 | 141928 | 0.020 |
Why?
|
| Urethane | 1 | 2005 | 11 | 0.020 |
Why?
|
| Bedding and Linens | 1 | 2005 | 10 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2007 | 286 | 0.020 |
Why?
|
| Abdominal Cavity | 1 | 2005 | 20 | 0.020 |
Why?
|
| Lung | 2 | 2008 | 3151 | 0.020 |
Why?
|
| Air | 1 | 2005 | 63 | 0.020 |
Why?
|
| Restraint, Physical | 1 | 2005 | 50 | 0.020 |
Why?
|
| Pressure | 1 | 2005 | 215 | 0.020 |
Why?
|
| Survival Rate | 1 | 2019 | 12221 | 0.020 |
Why?
|
| Immobilization | 1 | 2005 | 93 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2008 | 1014 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2016 | 15862 | 0.010 |
Why?
|
| Adult | 3 | 2016 | 77950 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 10001 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2009 | 1529 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 21713 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 4892 | 0.010 |
Why?
|
| Software | 1 | 2007 | 1321 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 10035 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2009 | 9244 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2009 | 6869 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2009 | 14889 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2005 | 15694 | 0.000 |
Why?
|